ArticleJornal brasileiro de nefrologia
Hematological indices derived from complete blood count and unfavorable outcomes in patients under-going peritoneal dialysis.
Article in Jornal brasileiro de nefrologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionUnderstanding the inflammatory processes that are associated with the risk of mortality in patients undergoing peritoneal dialysis (PD) may help guide clinical decision-making and risk and mortality stratification in this population.
objectiveTo evaluate the association of hematological indices derived from complete blood count with unfavorable outcomes in patients undergoing PD.
methodsProspective cohort with 43 patients undergoing PD follow up for 18 months. Complete blood count data were collected from medical records and the hematological indices were calculated for all participants in the four follow-up waves. Associations between these indices and classic inflammatory markers were investigated by correlation analyses. Patient survival was estimated by the Kaplan Meier method (K-M) after dividing the patients into two groups based on the median as the cut-off point for each hematological index. The Cox model with competitive-risk framework was used to evaluate the influence of indices on survival.
resultsThe AISI and SIRI indices had a significant positive correlation with global leukocytes (r = 0.74 and r = 0.71, respectively, p < 0.001). Only AISI and SII showed K-M significant estimates indicating greater survival for AISI ≤149.61 and SII ≤722.80. In the Cox regression model, patients who presented AISI above 149.6 and SII above 722.80 had 9.38 and 4.0 times, respectively, higher risk of death or transfer to HD than other patients.
conclusionAISI and SII were independently associated with the risk of unfavorable outcomes in PD patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.